Views & Analysis | Perspectives on pharma industry issues

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Market Access

Biotech's next growth cycle: Renewed confidence comes with c...

Renewed confidence across biopharma is welcome and long overdue after a prolonged period of constraint. But confidence alone is not enough.

Oncology

The future of oncology is adaptive: What ESMO 2026 revealed ...

Across tumours, three developments repeatedly surfaced throughout the congress, each reflecting a notable transition in how cancer is being managed.

Market Access

Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Articles

Gathering momentum to tackle antimicrobial resistance

We interview Dr John Rex of AstraZeneca to get an update on the NewDrugs4BadBugs programme and the challenge of antimicrobial resistance in general. Following on from our recent blog post by Dr John Rex we interview him for an update on the Innovative Medicines Initiative’s...

Articles

mHealth Monthly Mashup: release 13.0 – mobile health reality...

This month’s Mashup considers the mobile health space with cautious eyes… Americans are addicted to bubbles, enraptured by the oscillation of trillions of dollars that seemingly appear from nowhere only…

Articles

Strategy and evaluations part three: estimating discount rat...

Jean-Louis Roux Dix Buisson discusses how pharma companies can estimate discount rates in the final part of his three-part series. In my previous articles, we looked through the eye of the practitioner in order to propose...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital